These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2902873)

  • 1. Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.
    Macquin-Mavier I; Roudot-Thoraval F; Clerici C; George C; Harf A
    Br J Clin Pharmacol; 1988 Sep; 26(3):279-84. PubMed ID: 2902873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.
    Gribbin HR; Mackay AD; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1981 Jul; 12(1):61-5. PubMed ID: 6264936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 1/beta 2-splitting of bisoprolol.
    Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S65-8. PubMed ID: 2439801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Clin Pharmacol; 1982; 23(3):203-8. PubMed ID: 6756931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL; Levin DC; Manion CV
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
    Daul A; Johnston T; Reher M; Krüger M; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.
    Palminteri R; Kaik G
    Eur J Clin Pharmacol; 1983; 24(6):741-5. PubMed ID: 6136412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bisoprolol on local vascular resistance.
    Bailliart O; Kedra AW; Bonnin P; Savin E; Martineaud JP
    Eur Heart J; 1987 Dec; 8 Suppl M():87-93. PubMed ID: 2897303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ; Irvine NA; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.
    Dorow P; Tönnesmann U
    Eur J Clin Pharmacol; 1984; 27(2):135-9. PubMed ID: 6149938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.